Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

NCT04566887 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Acalabrutinib
DRUG: R-CHOP chemotherapy

Sponsor

University Health Network, Toronto